CareDx (CDNA) Research & Development (2013 - 2026)

CareDx has reported Research & Development for 14 years, with the latest figure at $33.4 million in Q2 2026.

• Quarterly Research & Development rose 37.74% year-over-year to $33.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $119.2 million (up 34.81% YoY) and the FY2025 annual result came in at $102.6 million, up 25.21% from the prior year.
• Research & Development rose to $33.4 million in Q2 2026 per CDNA's latest filing, from $30.4 million in the prior quarter.
• Over five years, Research & Development peaked at $33.4 million in Q2 2026 and troughed at $19.0 million in Q3 2023.
• A 5-year average of $23.9 million and a median of $23.1 million in 2022 frame the typical range for Research & Development.
• The sharpest annual moves came in 2023 and 2025: Research & Development declined 19.74% in 2023, then jumped 44.9% in 2025.
• Over 5 years, Research & Development stood at $23.7 million in 2022, then retreated by 13.5% to $20.5 million in 2023, then gained by 4.24% to $21.3 million in 2024, then surged by 44.9% to $30.9 million in 2025, then climbed by 8.14% to $33.4 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $33.4 million, $30.4 million, and $30.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.